Targeted treatment beyond third-line in metastatic Renal Cell Carcinoma (mRCC): Single center outcome of 22 patients

被引：0
|
作者：
Vallet, S. [1 ]
Hoefner, T. [2 ]
Pahernik, S. [2 ]
Tosev, G. [2 ]
Hadaschik, B. [2 ]
Duensing, S. [2 ]
Hohenfellner, M. [2 ]
Jaeger, D. [1 ]
Gruellich, C. [1 ]
机构：
[1] Univ Klin Heidelberg, Dept Med Oncol, Heidelberg, Germany
[2] Univ Klin Heidelberg, Dept Urol, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P288
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [1] ACTIVITY OF SUNITINIB AS THIRD-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) (JAPAN)
    Nozawa, M.
    Mochida, Y.
    Nishigaki, K.
    Nagae, S.
    Uemura, H.
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : I11 - I11
  • [2] Third-line treatment in metastatic renal cell carcinoma and bone metastases
    Heng, Daniel Y. C.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (7-8): : 268 - 268
  • [3] Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Stukalin, Igor
    Wells, Connor
    Donskov, Frede
    Rini, Brian I.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Smoragiewicz, Martin
    Alva, Ajjai Shivaram
    Srinivas, Sandy
    Wood, Lori
    Brugarolas, James
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Broom, Reuben James
    Kanesvaran, Ravindran
    Bamias, Aristotelis
    Knox, Jennifer J.
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] Clinical Outcome of Third-Line Pazopanib in a Patient with Metastatic Renal Cell Carcinoma
    Roberto, Michela
    Bassanelli, Maria
    Iannicelli, Elsa
    Giacinti, Silvana
    D'Antonio, Chiara
    Aschelter, Anna Maria
    Marchetti, Paolo
    [J]. CASE REPORTS IN ONCOLOGICAL MEDICINE, 2015, 2015
  • [5] Third-line Therapy for metastatic Renal cell carcinoma
    Rexer, H.
    [J]. ONKOLOGE, 2011, 17 (12): : 1161 - 1162
  • [6] Real-world treatment patterns in third-line patients with metastatic renal cell carcinoma (mRCC): The changing landscape in the United States
    Pal, Sumanta Kumar
    Malangone, Elisabetta
    Bhurke, Sharvari
    Gorritz, Magdaliz
    Stern, Lee
    Coombs, John
    Turnbull, James D.
    Wang, Xufang
    Liu, Zhimei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [7] Third-line Therapy for metastatic Renal Cell Carcinoma
    Rexer, H.
    [J]. UROLOGE, 2011, 50 (10): : 1319 - 1321
  • [8] Third-line dovitinib in metastatic renal cell carcinoma
    Schmidinger, Manuela
    [J]. LANCET ONCOLOGY, 2014, 15 (03): : 245 - 246
  • [9] Capecitabine as third-line treatment in patients with metastatic renal cell carcinoma after failing immunotherapy
    Petrioli, Roberto
    Paolelli, Loretta
    Francini, Edoardo
    Marsili, Stefania
    Pascucci, Alessandra
    Sciandivasci, Angela
    de Rubertis, Giovanni
    Barbanti, Gabriele
    Manganelli, Antonio
    Salvestrini, Francesco
    Francini, Guido
    [J]. ANTI-CANCER DRUGS, 2007, 18 (07) : 817 - 820
  • [10] Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Wells, J. Connor
    Stukalin, Igor
    Norton, Craig
    Srinivas, Sandy
    Lee, Jae Lyun
    Donskov, Frede
    Bjarnason, Georg A.
    Yamamoto, Haru
    Beuselinck, Benoit
    Rini, Brian I.
    Knox, Jennifer J.
    Agarwal, Neeraj
    Ernst, D. Scott
    Pal, Sumanta K.
    Wood, Lori A.
    Bamias, Aristotelis
    Alva, Ajjai S.
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    [J]. EUROPEAN UROLOGY, 2017, 71 (02) : 204 - 209
12345